Superior Group of Companies Reports Second Quarter 2026 Results

Adjusted earnings more than doubled, but headline net income fell on a $2.6M impairment.

What the company is saying

Superior Group of Companies, Inc. is presenting its second quarter 2026 results with an emphasis on adjusted performance metrics. The core narrative highlights a rise in net sales to $147.8 million and a sharp increase in adjusted net income to $3.2 million, or $0.21 per diluted share, more than double the prior year’s $0.10. The company frames the $2.6 million tradename impairment charge as a non-cash, one-off item in the Healthcare Apparel segment, using adjusted figures to underscore underlying earnings strength. Forward-looking guidance is positioned as incremental, forecasting full-year 2026 net sales of $572–$585 million and adjusted EPS of $0.54–$0.66, both up from 2025. The announcement’s tone is neutral and factual, with minimal promotional language. The dividend declaration of $0.14 per share is highlighted as a signal of stability. CEO Michael Benstock is named but not foregrounded as a central institutional signal.

What the data suggests

Net sales grew to $147,836,000 for the quarter, a 2.6% increase over the prior year’s $144,045,000. Adjusted EBITDA rose to $7,676,000 from $6,064,000, a 27% improvement, while adjusted net income more than doubled to $3,181,000 from $1,551,000. Despite these gains, reported net income fell to $1,221,000 due to a $2,600,000 tradename impairment charge in the Healthcare Apparel segment. Cash and cash equivalents stood at $22,787,000 as of June 30, 2026, and total assets were $408,520,000. The dividend of $0.14 per share is consistent with a stable payout policy. The company’s full-year 2026 sales and adjusted EPS guidance implies modest growth over 2025, but the absence of segment-level revenue or customer data limits deeper analysis. Some per-share figures, such as $0.08 for net income and $0.13 for the impairment, are not directly reconciled in the data, though overall disclosures are comprehensive.

Analysis

The announcement is a standard quarterly earnings release with a neutral tone and provides both GAAP and non-GAAP financial metrics. The majority of key claims are realised and supported by numerical data, such as net sales, adjusted EBITDA, and adjusted net income. Forward-looking statements are limited to full-year guidance for net sales and adjusted earnings per share, which are reasonable extensions of current performance rather than aspirational or promotional targets. There is no evidence of exaggerated language or narrative inflation; the language is factual and proportionate to the results. No large capital outlay or transformative investment is disclosed, and the benefits discussed are either already realised or expected within the current fiscal year. The absence of segment-level detail and some minor inconsistencies in per-share figures do not materially affect the overall signal.

Risk flags

• ●The $2.6 million tradename impairment charge in the Healthcare Apparel segment signals potential brand or segment underperformance, which could indicate ongoing challenges not fully captured in adjusted metrics.
• ●Reported net income declined year-over-year despite higher sales and improved adjusted earnings, highlighting the risk that one-off charges or operational issues could continue to impact GAAP profitability.
• ●The absence of segment-level revenue and margin breakdowns limits transparency into the sources of growth and risk, making it harder for investors to assess the durability of recent improvements.

Bottom line

Superior Group of Companies delivered modest sales growth and strong adjusted earnings in Q2 2026, but headline net income fell due to a $2.6 million impairment in Healthcare Apparel. The company’s guidance for the full year is for incremental improvement, not a step change, and all projections are near-term. Dividend continuity signals stability, but lack of segment detail and the impairment charge raise questions about the sustainability of performance. The narrative is credible at the headline and adjusted levels, but deeper insight into segment trends and recurring vs. non-recurring items would be needed for a stronger investment case. The most important takeaway: underlying adjusted profitability is improving, but headline results are vulnerable to one-off charges.

Announcement summary

(NASDAQ: SGC) Superior Group of Companies, Inc. announced second quarter 2026 net sales of $147.8 million, up from $144.0 million in the prior year second quarter. Net income for the quarter was $1.2 million, including a non-cash tradename impairment charge of $2.6 million ($2.0 million after tax), compared to $1.6 million in the prior year second quarter. Adjusted EBITDA was $7.7 million, up from $6.1 million in the prior year second quarter, and adjusted net income was $3.2 million or $0.21 per diluted share, more than double the prior year's $0.10 per diluted share. The Board of Directors declared a quarterly dividend of $0.14 per share, payable August 28, 2026 to shareholders of record as of August 14, 2026. The company continues to forecast full-year 2026 net sales in the range of $572.0 million to $585.0 million, up from 2025 net sales of $566.2 million, and full-year adjusted earnings per diluted share in the range of $0.54 to $0.66, up from $0.46 in 2025. As of June 30, 2026, cash and cash equivalents were $22,787,000, and total assets were $408,520,000. The company recorded a tradename impairment charge in the Healthcare Apparel segment of $2.6 million during the quarter.

Disagree with this article?